Residents

Enrich Bioscience

Enrich Bioscience

Enrich Bioscience has a new technology that can test 1000’s of cDMRs (cancer Differentially Methylated Region) simultaneously without decreasing sensitivity and accuracy. This technology has the potential to detect different cancers, including, lung, liver, bladder, prostate, colorectal, breast, pancreatic, thyroid, gastric cancer and leukemia; using many cDMRs for each cancer type in a single test. The list of detectable cancers will grow as research advances.

Area of focus: 
Diagnostics, Oncology
Commencement date: 
05/15/2017

Share